Highlights:

• Introduction of the 4 key areas (1:08)
• The pathway to SG&A profitability (4:19)
• What it takes to succeed in medical (6:25)
• The importance of building relationships with regulators (9:47)
• The future of cannabinoids (14:50)
• Dynamic nature of the cannabis market (18:21)
• Breakdown of the science and innovation unit of Aurora (19:55)
• The pathway to EBITDA profitability (24:02)
• Aurora's next steps (26:07)

Links:

ICR Twitter

ICR LinkedIn

ICR Website

Miguel Martin LinkedIn

Aurora Website

Aurora LinkedIn

Aurora Twitter

Feedback:

If you have questions about the show or topics you'd like discussed in future episodes, email our producer, andrew@lowerstreet.co